Search Results for Merrimack Pharmaceuticals (Corporate Dealmaker)

Tuesday, November 24,

8:25 pm

  • Log in to The Deal Pipeline
  • Subscribe to The Deal magazine
  • Products & services

Corporate Dealmaker: Helping companies succeed in the deal economy.

Syndicate

Subscribe to our RSS feed

Contributors

Search Results

Advanced Search

Sort ByDate Relevance	Search InCorporate Dealmaker The entire Deal Blogs Network

1 result(s) displayed (1 - 1 of 1):

Sanofi-Merrimack deal keeps trend alive (from Corporate Dealmaker)

Our oncology M&A list keeps growing. Sanofi-Aventis SA (NYSE:SNY), which is already on it, is acquiring the rights to sell an experimental cancer treatment developed by Merrimack Pharmaceuticals Inc. for up to $530 million. The Deal Pipeline (subscription required) has details on the transaction.The Merrimack deal comes after a setback...

Posted on October 1, 2009 2:06 PM

Movable Type search results powered by Fast Search

Search

Corporate Dealmaker Video

Deal Economy 2010: IBM's Mendoza on IT services M&A

IBM's Elias Mendoza on the company's future strategic moves.

Movers & Shakers

Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.

Juergen Lasowski, Onyx Pharmaceuticals Inc.

Edward Swallow, Northrop Grumman Corp.

Owen Mahoney, Outspark

Alice Kim, FLO TV Inc.

Eric Hausler, Isle of Capri Casinos Inc.

COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine

And the winners are...

Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue